Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Conditions
Anatomic Stage IV Breast Cancer AJCC v8 · Invasive Breast Carcinoma · Metastatic Triple-Negative Breast Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
UCHealth University of Colorado Hospital, Aurora, Colorado, United States
Contact: Principal Investigator (Jennifer R. Diamond)Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States
Yale University, New Haven, Connecticut, United States
UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida, United States
Contact: Principal Investigator (Alejandra T. Perez)UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States
Contact: Principal Investigator (Alejandra T. Perez)UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States
Contact: Principal Investigator (Alejandra T. Perez)University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
Contact: Principal Investigator (Alejandra T. Perez)UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States
Contact: Principal Investigator (Alejandra T. Perez)UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States
Contact: Principal Investigator (Alejandra T. Perez)Moffitt Cancer Center-International Plaza, Tampa, Florida, United States
Contact: Principal Investigator (Aixa E. Soyano)Moffitt Cancer Center - McKinley Campus, Tampa, Florida, United States
Contact: Principal Investigator (Aixa E. Soyano)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Aixa E. Soyano)Moffitt Cancer Center at Wesley Chapel, Wesley Chapel, Florida, United States
Contact: Principal Investigator (Aixa E. Soyano)Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Cesar A. Santa-Maria)Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States
Contact: Principal Investigator (William E. Gillanders)Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
Contact: Principal Investigator (William E. Gillanders)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (William E. Gillanders)Siteman Cancer Center-South County, St Louis, Missouri, United States
Contact: Principal Investigator (William E. Gillanders)Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States
Contact: Principal Investigator (William E. Gillanders)Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, United States
NYP/Weill Cornell Medical Center, New York, New York, United States
Contact: Principal Investigator (Massimo Cristofanilli)Wake Forest University at Clemmons, Clemmons, North Carolina, United States
Contact: Principal Investigator (Emily H. Douglas)Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Emily H. Douglas)Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (Kai C. Johnson)University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Julia Foldi)University of Texas Medical Branch, Galveston, Texas, United States
Contact: Principal Investigator (Avi B. Markowitz)VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States
Contact: Principal Investigator (Masey M. Ross)
Study leads
William E Gillanders
Principal Investigator
Yale University Cancer Center LAO